264 related articles for article (PubMed ID: 34550543)
1. Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression.
Khan N; Halcrow PW; Lakpa LK; Rehan M; Chen X; Geiger JD
J Neurovirol; 2021 Oct; 27(5):755-773. PubMed ID: 34550543
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Tat endocytosis and retention in endolysosomes affects HIV-1 Tat-induced LTR transactivation in astrocytes.
Khan N; Halcrow PW; Afghah Z; Baral A; Geiger JD; Chen X
FASEB J; 2022 Mar; 36(3):e22184. PubMed ID: 35113458
[TBL] [Abstract][Full Text] [Related]
3. BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation.
Khan N; Lakpa KL; Halcrow PW; Afghah Z; Miller NM; Geiger JD; Chen X
Sci Rep; 2019 Aug; 9(1):12285. PubMed ID: 31439883
[TBL] [Abstract][Full Text] [Related]
4. Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation.
Khan N; Halcrow PW; Lakpa KL; Afghah Z; Miller NM; Dowdy SF; Geiger JD; Chen X
FASEB J; 2020 Mar; 34(3):4147-4162. PubMed ID: 31950548
[TBL] [Abstract][Full Text] [Related]
5. Endolysosome Iron Chelation Inhibits HIV-1 Protein-Induced Endolysosome De-Acidification-Induced Increases in Mitochondrial Fragmentation, Mitophagy, and Cell Death.
Halcrow PW; Kumar N; Quansah DNK; Baral A; Liang B; Geiger JD
Cells; 2022 May; 11(11):. PubMed ID: 35681506
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation.
Khan N; Datta G; Geiger JD; Chen X
J Neuroinflammation; 2018 Mar; 15(1):91. PubMed ID: 29558961
[TBL] [Abstract][Full Text] [Related]
7. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression.
Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W
Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541
[TBL] [Abstract][Full Text] [Related]
8. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 gp120-Induced Endolysosome de-Acidification Leads to Efflux of Endolysosome Iron, and Increases in Mitochondrial Iron and Reactive Oxygen Species.
Halcrow PW; Lakpa KL; Khan N; Afghah Z; Miller N; Datta G; Chen X; Geiger JD
J Neuroimmune Pharmacol; 2022 Jun; 17(1-2):181-194. PubMed ID: 33834418
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
Schafer SL; Vlach J; Pitha PM
J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation.
Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS
Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.
Henderson LJ; Narasipura SD; Adarichev V; Kashanchi F; Al-Harthi L
J Virol; 2012 Sep; 86(17):9495-503. PubMed ID: 22674979
[TBL] [Abstract][Full Text] [Related]
13. Akt/Nox2/NF-κB signaling pathway is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation.
Zhang HS; Sang WW; Ruan Z; Wang YO
Arch Biochem Biophys; 2011 Jan; 505(2):266-72. PubMed ID: 21029719
[TBL] [Abstract][Full Text] [Related]
14. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
Zhang HS; Ruan Z; Sang WW
J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
[TBL] [Abstract][Full Text] [Related]
15. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
17. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
18. ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.
Bruce JW; Reddington R; Mathieu E; Bracken M; Young JA; Ahlquist P
PLoS Pathog; 2013 Oct; 9(10):e1003712. PubMed ID: 24204263
[TBL] [Abstract][Full Text] [Related]
19. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD(+)-dependent SIRT1 activity.
Zhang HS; Zhou Y; Wu MR; Zhou HS; Xu F
Life Sci; 2009 Sep; 85(13-14):484-9. PubMed ID: 19664641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
